Thank you.
I'd like to direct my question to the ALS group.
I had a round table with an ALS group of sufferers, and they were very clear that they don't have time. It looks as if the changes to the PMPRB are going to make it even more difficult for them to get the medicines they need.
Could you speak to that challenge? Will the changes to the PMPRB affect their access to the new treatment for ALS that's available?